Side-by-side comparison of AI visibility scores, market position, and capabilities
Houston Sunbelt multifamily REIT (NYSE: CPT) ~$1.6B FY2024 revenue; 58K homes in 58 communities, supply-cycle navigation, Sunbelt migration demand competing with Equity Residential and MAA.
Camden Property Trust is a Houston, Texas-based apartment REIT (Real Estate Investment Trust) — publicly traded on the New York Stock Exchange (NYSE: CPT) as an S&P 500 Real Estate component — owning, developing, acquiring, and managing high-quality multifamily apartment communities in high-growth Sunbelt and coastal US markets including Houston, Atlanta, Dallas, Phoenix, Tampa, Orlando, Washington DC, and Southern California through approximately 1,800 employees. Camden Property Trust owns approximately 58,000 apartment homes in 58 communities across 15 markets, with a development pipeline targeting high-demand urban infill and suburban lifestyle communities with amenities (resort-style pools, fitness centers, dog parks, coworking spaces) that appeal to professional renter demographics. In fiscal year 2024, Camden reported revenues of approximately $1.6 billion, with same-store net operating income growth moderating from the exceptional 2021-2023 period when pandemic-driven domestic migration to Sunbelt markets drove double-digit rent growth — as the 2024 Sunbelt apartment market faced elevated new supply (record apartment completions in Dallas, Austin, Phoenix, and Tampa where construction started during 2021-2022 demand surge) that created concessions and slowed rent growth to low single digits. CEO Richard Campo has navigated the apartment supply cycle by concentrating Camden's development activity on markets with constrained new supply and development pipeline discipline — pausing new development starts in oversupplied markets while maintaining the operating portfolio's amenity investment that supports premium rent positioning versus commodity apartment alternatives.
San Jose clear aligner orthodontics inventor (NASDAQ: ALGN) at $3.23B 2024 revenue; 20 million Invisalign patient milestone Q1 2025 across 280,000+ doctors with iTero Lumina scanner competing with 3M Clarity for orthodontic clear aligner prescriptions.
Align Technology, Inc. is a San Jose, California-based global medical device company — publicly traded on NASDAQ (NASDAQ: ALGN) as an S&P 500 component — operating as the inventor of the Invisalign System and the world leader in clear aligner orthodontics, reaching 20 million Invisalign patients treated worldwide in Q1 2025 through a network of 280,000+ Invisalign-trained doctors across 100+ countries. In fiscal year 2024, Align reported $3.23 billion in total revenue with Q4 2024 revenue of $995.2 million (+4.0% year-over-year). Align's product portfolio comprises the Invisalign System of clear aligners, iTero intraoral digital scanners (including the iTero Lumina with 3X wider field of capture in a 50% smaller wand), and exocad CAD/CAM software for digital dental workflows. Manufacturing is based in Mexico with treatment planning performed in Costa Rica. CEO Joseph Hogan joined from GE Healthcare in 2015. Founded 1997 by Zia Chishti and Kelsey Wirth in San Jose.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.